The business model of the pharmaceutical industry is changing fast: The era of blockbuster medications with big margins is over. Instead, patient-centric medication is the way forward. While the industry is still grappling with these facts competition from another side is entering the field: tech companies are currently investing heavily to reap large profits from e-health concepts. In the article the authors discuss how pharma companies can react in order to survive in this new environment.
Twice a year, Arthur D. Little covers the latest cutting-edge thinking on strategy, technology and innovation in its corporate magazine Prism. For over 20 years Prism has continually set the standards in innovative thinking and groundbreaking concepts in the world of business and management.